Reporting Conflicts of Interest, Financial Aspects of Research, and Role of Sponsors in Funded Studies
- Phil B. Fontanarosa, MD, MBA;
- Annette Flanagin, RN, MA;
- Catherine D. DeAngelis, MD, MPH
- Author Affiliations: Dr Fontanarosa is Executive Deputy Editor (phil.fontanarosa@jama-archives.org), Ms Flanagin is Managing Deputy Editor, and Dr DeAngelis is Editor-in-Chief, JAMA.
Since this article does not have an abstract, we have provided the first 150 words of the full text.
Research studies in biomedical journals are increasingly scrutinized, not only for their scientific findings and clinical and public health implications, but also because of concerns related to conflicts of interest of investigators1 and concerns about misleading reporting of industry-sponsored research.2 The perception that conflicts of interest or financial concerns may have potentially detrimental effects on medical science has prompted medical journals to critically examine and more vigorously enforce policies for disclosure of potential conflicts and for reporting of relationships with industry.3
The need for transparency in reporting the financial conflicts of interest of authors and the relationships between investigators and funding sources has never been greater and is essential to help maintain confidence and trust in the scientific integrity of medical research articles. In this editorial, we review and update our policies for authors reporting conflicts of interest and disclosing financial support and other paid contributions for …
